IBL International’s MuSk-Ab ELISA is proving invaluable for the diagnosis and monitoring of ‘seronegative’ myasthenia gravis (MG). This test is the world’s first commercially available, non-radioactive assay for the detection of auto-antibodies against the muscle-specific receptor tyrosine kinase (MuSK), and is helping to improve diagnostic confidence and aid clinical management of these patients.
